Humana Inc. (NYSE:HUM) Shares Sold by Vestcor Inc

Key Points

• Vestcor Inc significantly reduced its stake in Humana Inc. by 59.4%, leaving it with 2,404 shares valued at approximately $636,000.
• Humana reported earnings of $6.27 per share for the last quarter, missing the analysts' estimate of $6.32, while revenue increased by 9.6% year-over-year to $32.39 billion.
• Equities analysts have set varied price targets for Humana, with an average price target of $281.62 and most ratings leaning towards a "Hold."

Vestcor Inc lessened its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 59.4% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,404 shares of the insurance provider's stock after selling 3,510 shares during the quarter. Vestcor Inc's holdings in Humana were worth $636,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Riverview Trust Co acquired a new position in shares of Humana in the first quarter worth $34,000. Garde Capital Inc. purchased a new position in shares of Humana in the 1st quarter valued at about $36,000. Transce3nd LLC acquired a new position in shares of Humana during the fourth quarter worth about $38,000. Whipplewood Advisors LLC increased its stake in shares of Humana by 639.1% during the first quarter. Whipplewood Advisors LLC now owns 170 shares of the insurance provider's stock worth $45,000 after buying an additional 147 shares during the period. Finally, Colonial Trust Advisors raised its holdings in Humana by 4,500.0% in the fourth quarter. Colonial Trust Advisors now owns 184 shares of the insurance provider's stock valued at $47,000 after acquiring an additional 180 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on HUM. Wells Fargo & Company set a $348.00 price objective on shares of Humana in a research report on Friday, July 18th. Truist Financial lowered their price objective on Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research report on Wednesday, July 16th. Morgan Stanley lowered their price target on Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a report on Thursday, July 31st. Barclays set a $275.00 price objective on shares of Humana and gave the stock an "equal weight" rating in a report on Thursday, July 31st. Finally, Wall Street Zen cut Humana from a "buy" rating to a "hold" rating in a research report on Saturday. Seventeen investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, Humana has an average rating of "Hold" and an average target price of $281.62.

Humana Price Performance

Shares of NYSE HUM traded up $7.60 during trading on Tuesday, reaching $254.95. The company had a trading volume of 1,936,925 shares, compared to its average volume of 1,940,093. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The stock has a market capitalization of $30.66 billion, a PE ratio of 19.57, a price-to-earnings-growth ratio of 1.45 and a beta of 0.44. Humana Inc. has a twelve month low of $206.87 and a twelve month high of $382.72. The stock has a 50-day moving average price of $235.53 and a two-hundred day moving average price of $254.67.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%. The firm had revenue of $32.39 billion for the quarter, compared to analysts' expectations of $31.85 billion. During the same quarter last year, the firm earned $6.96 earnings per share. The business's quarterly revenue was up 9.6% compared to the same quarter last year. As a group, sell-side analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.